Yugang Hu
Overview
Explore the profile of Yugang Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
965
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang X, Ye H, Hu Y, Lei Y, Tian Y, Huang X, et al.
Cancer Imaging
. 2025 Jan;
25(1):1.
PMID: 39773358
Background: Prostate cancer (PCa) is the leading cause of cancer-related morbidity and mortality in men worldwide. An early and accurate diagnosis is crucial for effective treatment and prognosis. Traditional invasive...
2.
Ultrasound super-resolution imaging for the assessment of renal allograft dysfunction: A pilot study
Hu Y, Lei Y, Yu M, Zhang Y, Huang X, Zhang G, et al.
Heliyon
. 2024 Sep;
10(16):e36515.
PMID: 39247269
Background: The purpose of this study was to examine the feasibility and practical application of ultrasound (US) super-resolution imaging (SRI) in evaluating microvasculature and measuring renal allograft function. Methods: Sixteen...
3.
Lu D, Tu L, Hu Y, Cai X
PLoS One
. 2024 Aug;
19(8):e0306884.
PMID: 39208322
Background: We proposed a link between the first systemic inflammatory response index (SIRI) and acute kidney injury (AKI), as well as the prognosis of pediatric patients in intensive care units...
4.
Huang X, Hu Y, Zhang Y, Zhou Q
Int J Gen Med
. 2024 May;
17:1877-1885.
PMID: 38736665
Objective: To establish a radiomics nomogram based on two-dimensional ultrasound for risk assessment of diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM). Methods: This study retrospectively...
5.
Huang X, Chen Y, Zhong F, Gui B, Hu Y, Guo Y, et al.
Int J Nanomedicine
. 2024 Mar;
19:2793-2806.
PMID: 38525011
Background: Prostate cancer (PCa) poses a significant global health threaten. Immunotherapy has emerged as a novel strategy to augment the inhibition of tumor proliferation. However, the sole use of anti-PD-L1...
6.
Chen Y, Wang H, Pan J, Guo Y, Hu Y, Huang X, et al.
Atherosclerosis
. 2023 Dec;
389:117423.
PMID: 38159431
Background And Aims: Sonodynamic therapy (SDT) is a new approach for the treatment of atherosclerosis (AS), yet the poor targeting ability of sonosensitizers limits its therapeutic efficacy. Herein, we reported...
7.
Yang H, Hu Y, Kong B, Zhou Y, Shuai W
Int Immunopharmacol
. 2023 Dec;
126:111317.
PMID: 38048669
Background: Sympathetic overactivation plays an important role in heart failure (HF)-induced ventricular arrhythmias (VAs). Microglia-mediated neuroinflammation could contribute to sympathetic overactivation. A previous study demonstrated that low-intensity pulsed ultrasound (LIPUS)...
8.
Cao Q, Liu L, Hu Y, Cao S, Tan T, Huang X, et al.
Front Immunol
. 2023 Sep;
14:1248056.
PMID: 37744362
Introduction: The prevalence of ischemic heart disease has reached pandemic levels worldwide. Early revascularization is currently the most effective therapy for ischemic heart diseases but paradoxically induces myocardial ischemia/reperfusion (MI/R)...
9.
Wang H, Guo Y, Hu Y, Zhou Y, Chen Y, Huang X, et al.
Int J Biol Macromol
. 2023 Jun;
244:125139.
PMID: 37268076
Heart failure is a critical and ultimate phase of cardiovascular ailment that leads to a considerable incidence of disability and mortality. Among various factors contributing to heart failure, myocardial infarction...
10.
Pan J, Chen Y, Hu Y, Wang H, Chen W, Zhou Q
Front Bioeng Biotechnol
. 2023 May;
11:1152067.
PMID: 37122864
Cardiovascular and cerebrovascular diseases are major global health problems, and the main cause is atherosclerosis. Recently, molecular imaging has been widely employed in the diagnosis and therapeutic applications of a...